TSE:MFC

Manulife Financial (MFC.TO)

54.16
+0.66 (1.23%)
as of Jun 5, 2026, 3:33:54 pm Market Open.
1636 watching
0
Investor Insights
star iconJun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by several analysts, who note its solid growth in Asia and the wealth management sector. The company is seen as a stable and reliable option, with a decent dividend yield that appeals to income-focused investors. Analysts acknowledge that while MFC has experienced some recent challenges, especially in its U.S. operations and corrections after strong performances, it maintains a healthy growth outlook. Concerns about the overall market and macroeconomic factors have led to suggestions of caution, but many believe MFC's valuation is still attractive relative to its peers, particularly the banks. In the long term, it remains a compelling investment opportunity with the potential for growth, other factors such as credit risk being minimal.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
TOP PICK
Believes stock is very cheap. Not sensitive to market moves. Capital ratios and other major metrics improved, yet still cheap stock. Business is a solid, boring business.
STRONG BUY
Raised dividend by 18%. Growing business in NA and China. 80% of business is based on fixed income. If we see rising rates, will definitely benefit. Attractive proposition right now. Seasonally also tends to do well at this time. Yield is over 5%.
WEAK BUY
Why is this undervalued given its positive metrics? The answer is MFC's exposure to China, one of the worst-performing asset classes this year, which is surprising given the lack of Covid cases. Lifecos historically are a very good way to play rising interest rates. That could be another factor to like MFC.
BUY
Trades at a discount. Asia has powered much of its growth. No problems owning it in a rising interest rate environment. He's looking at EPS in the $4 range over the next couple of years, and a dividend of 5.5%. Starting to be more generous in dividends.
HOLD
MFC vs. SLF Both struggling. Have to invest in fixed income at low rates. Both problems growing business. MFC has struggled more with its international expansion. Neither is a great longer term grower. He'd choose MFC because of the dividend. If you sell one, pay attention to the tax hit. Yield is 4.6%, safe. SLF yield is around 3%.
PAST TOP PICK
(A Top Pick Dec 02/20, Up 8%) Double digit dividend increase. Perennially cheap, in stark contrast to its earnings growth rate. Good footprint in Canada, US, and Asia. Sees good upside, continues to buy.
BUY
Manulife vs. Canadian Tire as a dividend play He nearly made MFC a top pick today. He'd certainly buy. They just hiked their dividend and in the US they offloaded a lot of long-term risk. He through the market would have been more positive about the latter. Pays a 5.5% dividend now. Catalysts are head driven by new managers. He prefers MFC over Canadian Tire which faces rising input costs, lots of competition and weaker management. That said, CT is a decent investment.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly We reiterate MFC, a Canadian based financial and wealth services provider, as a TOP PICK. It pays a strong dividend backed by a payout ratio of 33% of cash flow. It trades only 7x current earnings, compared to peers at 12x, and it is valued right near book value. We recommend trailing up the previously recommended stop (from $17) to $21 looking to achieve $30 -- over 29% upside. Yield 4.7% (Analysts’ price target is $30.00)
BUY
Insanely cheap. Under 8x earnings. Dividend yield 5%. Improved capital ratio dramatically. Lifecos benefit a bit more from rising rates, and they're all trying to reduce their sensitivity to rates by diversifying into wealth management.
PAST TOP PICK
(A Top Pick Dec 03/20, Up 13%) Interest rate sensitivity has been dialed down since the financial crisis, but it's still there. Especially likes the excellent wealth and asset business, as well as exposure to the Asian EM consumer. Undemanding valuation at 7-8x earnings, yield of about 4%. Major discount to banks and peers. Good upside and re-rating potential.
WEAK BUY
It has not been performing well in the last few months but is a stable trade going forward. He likes their exposure in Asia.
BUY
Has disappointed a lot of people for a while. The valuation is silly, trading at 6x whereas Sunlife is at 10x. There is still tail risk with variable annuities. Operationally, they are doing well with good growth in Asia. 9-10% EPS growth trading at 6.6x. Comfortable owning it. Thinks it will work at these levels.
COMMENT
They have grown a franchise in Asia, and there's more upside there in life insurance whereas North America is saturated. MFC has had historic issues in investing, which has kept him away. The accounting can be complex in this business. He owns no lifecos.
HOLD
It has been a weaker performer and it comes down to the John Hancock division in the US. In the next 12-18 months they should work through this. He'd prefer BNS-T for yield.
PARTIAL SELL
Insurance companies have been quite sleepy this year. SLF stock's been flat since 2019. Not a ton of dividend growth. Good positive exposure to rising rates longer term. Well managed. MFC has more catalysts, cheaper, higher dividend yield. Trimmed weighting to insurance broadly and moved into utilities, renewables, and infrastructure.
Showing 211 to 225 of 2,279 entries